TETRAPEPTIDE TYROSINE KINASE INHIBITORS - ENANTIOSELECTIVE SYNTHESIS OF P-HYDROXYMETHYL-L-PHENYLALANINE, INCORPORATION INTO A TETRAPEPTIDE,AND SUBSEQUENT ELABORATION INTO P-(R,S-HYDROXYPHOSPHONOMETHYL)-L-PHENYLALANINE
Mh. Kim et al., TETRAPEPTIDE TYROSINE KINASE INHIBITORS - ENANTIOSELECTIVE SYNTHESIS OF P-HYDROXYMETHYL-L-PHENYLALANINE, INCORPORATION INTO A TETRAPEPTIDE,AND SUBSEQUENT ELABORATION INTO P-(R,S-HYDROXYPHOSPHONOMETHYL)-L-PHENYLALANINE, International journal of peptide & protein research, 44(5), 1994, pp. 457-465
A convenient enantioselective synthesis of p-hydroxymethyl-L-phenylala
nine was developed which produces a 4/1 ratio of L/D enantiomers resul
ting from a chiral phase-transfer-catalyzed alkylation. This amino aci
d was coupled into the p56(lck) tyrosine kinase substrate Ac-Leu-Pro-T
yr-Ala-NHCH3 as a replacement for Tyr and can subsequently be elaborat
ed into a variety of potential tyrosine kinase inhibitor designs of ge
neral structure Ac-Leu-Pro-AA-Ala-NHCH3, wherein AA is an unnatural am
ino acid. The contaminating D enantiomer was readily removed after cou
pling to L-Ala-NHCH3 of this sequence. The utility of the p-hydroxymet
hyl functionality in an efficient divergent synthetic strategy leading
to various inhibitor designs is illustrated with the synthesis of Ac-
Leu-Pro-AA-Ala-NHCH3, wherein AA is p-(R,S-hydroxyphosphonomethyl)-L-p
henylalanine. (C) Munksgaard 1994.